0.3035
-0.0035
(-1.14%)
At close: January 31 at 5:35:05 PM GMT+1
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-23,125.0000
-18,481.0000
-5,392.0000
Investing Cash Flow
--
132.0000
-175.0000
4,949.0000
Financing Cash Flow
--
8,643.0000
13,409.0000
19,584.0000
End Cash Position
--
27,650.0000
41,970.0000
47,195.0000
Capital Expenditure
--
-42.0000
-8.0000
-20.0000
Issuance of Capital Stock
--
218.0000
91.0000
--
Issuance of Debt
--
8,964.0000
13,713.0000
20,597.0000
Repayment of Debt
--
-165.0000
--
--
Repurchase of Capital Stock
--
--
--
-633.0000
Free Cash Flow
--
-23,167.0000
-18,489.0000
-5,412.0000
12/31/2020 - 4/12/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0NZU.IL Zealand Pharma A/S
747.50
+1.74%
OSE.PA OSE Immunotherapeutics SA
6.81
+2.41%
ALVIO.PA Valerio Therapeutics Société anonyme
0.0780
+1.30%
ALGAE.PA FERMENTALG
0.3840
+1.32%
ALVAL.PA Valbiotis SA
1.4180
+3.20%
ADOC.PA Adocia SA
5.86
-0.34%
SCNI Scinai Immunotherapeutics Ltd.
3.5887
+3.72%
NANO.PA Nanobiotix S.A.
3.5000
+2.10%
PMCB PharmaCyte Biotech, Inc.
1.6049
-1.54%
GNFT.PA Genfit S.A.
3.5750
-2.85%